Whistleblower Litigation in NY & PA

The Federal False Claims Act authorizes private citizens, called relators or “whistleblowers,” to file claims on behalf of the United States. In these cases, known as qui tam actions, the whistleblower may receive up to 30% of the proceeds recovered by the government, plus other damages in certain circumstances. The proceeds are offered by law to provide incentives for whistleblowers to come forward and expose fraud against the government.  In 2012 alone, approximately $5 billion was recovered in cases brought under the False Claims Act. The whistleblowers’ share of those recoveries was $431 million.

Qui tam cases handled with knowledge and resourcefulness

Using the same skills that have enabled attorneys at Lowey Dannenberg Cohen & Hart, P.C. to recover hundreds of millions of dollars for private clients asserting similar claims in civil litigation, Lowey Dannenberg has filed numerous qui tam false claim recovery lawsuits in the name of the United States under the False Claims Act. In 2009, we filed two separate qui tam relater actions in the United States District Court for the Southern District of New York. While confidentiality restrictions mandate that both complaints remain sealed, we can relate that one concerns a scheme by a major United States pharmaceutical company, in tandem with New York City hospital personnel, to systematically send fraudulent billings to Medicare and Medicaid. The other concerns fraud against the United States Treasury Department involving financial products. Our experienced and resourceful attorneys will vigorously work with whistleblowers and public servants to prosecute qui tam false claim recoveries, particularly those regarding financial matters or Medicare and Medicaid.

Equipped to handle the most complex qui tam cases

In addition, we help whistleblowers unveil corporate and government malfeasance, helping to ensure that ethical practices are at the forefront of business and government. It is our experience litigating similar cases for four of the largest health benefit providers and institutional investors that allows us to bring such acumen to your consumer litigation case.

In conjunction with related qui tam litigation, we have prosecuted major-scale civil fraud recovery actions for many years. For example, while the qui tam bar pursued what was at the time one of the largest civil Medicare and Medicaid fraud cases in history alleging that TAP Pharmaceuticals paid doctors kickbacks to over-prescribe the cancer drug Lupron, Lowey Dannenberg prosecuted a civil action and ultimately negotiated a $110 million settlement for private third party payers. This unique experience in the healthcare field, particularly dealing with third party payers, equips our firm with the necessary manpower and skill set to prosecute qui tam cases with vigor. We have the benefit of years of experience at the forefront of medical and pharmaceutical recovery actions, the depth of experienced lawyers and support staff and the resources that make us the law firm of choice for the most diverse, blue-chip clientele of health benefits payers of any U.S. plaintiff's law firms. Lowey Dannenberg brings these extremely transferrable skills and abilities to our prosecuting of financial, Medicare and Medicaid qui tam litigation.

Contact us.

If you or your institution has been harmed, nationally-recognized Lowey Dannenberg has the experience needed to handle your complex litigation needs. Speak with an attorney at our offices in New York or Pennsylvania online or at 914-997-0500.